Japan, April 22 -- JANSSEN PHARMACEUTICA NV has got intellectual property rights for 'FORMULATIONS/COMPOSITIONS COMPRISING IBRUTINIB.' Other related details are as follows:
Application Number: JP,2023-191535
Category (FI): A61K47/02,A61K47/04,A61K47/42,A61K47/38,A61K47/36,A61K47/40,A61K47/20,A61K47/22,A61K47/18,A61K47/14,A61K47/12,A61K47/10,A61K9/10,A61P7/00,A61P35/02,A61P35/00,A61K31/519
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Nov. 9, 2023
Publication Date: Feb. 21, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....